Showing 1,621 - 1,640 results of 4,100 for search '(( significantly lower decrease ) OR ( significantly larger decrease ))*', query time: 0.30s Refine Results
  1. 1621

    Production function regression ridge trace. by Zijie Li (776536)

    Published 2025
    “…In the stage of high-quality development (2012 present), the contribution rate of technological factors continued to rise and become the dominant factor, while the contribution rate of land factors has decreased to a lower level. (2) Regarding spatial characteristics, the spatial econometric model reveals significant spatial agglomeration characteristics of capital and labor, and land factors positively affect local and neighboring economic growth. …”
  2. 1622

    Model test results. by Zijie Li (776536)

    Published 2025
    “…In the stage of high-quality development (2012 present), the contribution rate of technological factors continued to rise and become the dominant factor, while the contribution rate of land factors has decreased to a lower level. (2) Regarding spatial characteristics, the spatial econometric model reveals significant spatial agglomeration characteristics of capital and labor, and land factors positively affect local and neighboring economic growth. …”
  3. 1623
  4. 1624
  5. 1625

    Primers for quantitative real-time PCR. by Ya-nan Hu (12508990)

    Published 2024
    “…However, LDLR protein levels in the cell lysate of both the Gly343Ser and Ala627Thr variants groups were significantly lower than those in the wild-type group. …”
  6. 1626

    Descriptive data for the pBT-child dyads. by Madalina Ciobanu (2504683)

    Published 2025
    “…<div><p>Autism spectrum disorder (ASD) is a condition with growing prevalence that results in significant healthcare spending, reduced parent income, high levels of family stress, and decreased quality of life (QoL). …”
  7. 1627

    CFQL-2 descriptive statistics. by Madalina Ciobanu (2504683)

    Published 2025
    “…<div><p>Autism spectrum disorder (ASD) is a condition with growing prevalence that results in significant healthcare spending, reduced parent income, high levels of family stress, and decreased quality of life (QoL). …”
  8. 1628

    O<sub>2</sub> concentration under different conditions. by Zihao Chai (20521844)

    Published 2025
    “…Regarding the oxygen consumption activation energy, the primary oxidation process exhibited lower values in the first and second stages, but in the third stage, the secondary oxidation process at 25 mL/min and 100 mL/min air flow had lower oxygen consumption activation energy, while at 50 mL/min and 200 mL/min air flow, the primary oxidation process had lower oxygen consumption activation energy. …”
  9. 1629

    This is the paper’s data. by Zihao Chai (20521844)

    Published 2025
    “…Regarding the oxygen consumption activation energy, the primary oxidation process exhibited lower values in the first and second stages, but in the third stage, the secondary oxidation process at 25 mL/min and 100 mL/min air flow had lower oxygen consumption activation energy, while at 50 mL/min and 200 mL/min air flow, the primary oxidation process had lower oxygen consumption activation energy. …”
  10. 1630

    O<sub>2</sub> concentration under different conditions. by Zihao Chai (20521844)

    Published 2025
    “…Regarding the oxygen consumption activation energy, the primary oxidation process exhibited lower values in the first and second stages, but in the third stage, the secondary oxidation process at 25 mL/min and 100 mL/min air flow had lower oxygen consumption activation energy, while at 50 mL/min and 200 mL/min air flow, the primary oxidation process had lower oxygen consumption activation energy. …”
  11. 1631
  12. 1632
  13. 1633
  14. 1634
  15. 1635
  16. 1636
  17. 1637
  18. 1638

    Participant flow (CONSORT diagram). by David J. Diemert (8135568)

    Published 2024
    “…Peak anti-<i>Na</i>-GST-1 IgG levels were observed between 2 and 4 weeks following the third dose, regardless of <i>Na</i>-GST-1 formulation. IgG levels decreased but remained significantly above baseline in all groups by day 290, at which point all participants (20 of 20 evaluable participants) still had detectable IgG. …”
  19. 1639
  20. 1640

    Study data. by Jie Liu (15128)

    Published 2025
    “…The drug cost of the roxadustat group was higher, but another additional cost for correcting anemia was significantly reduced. The infection rate of COVID-19 and the mortality rate caused by COVID-19 were lower in roxadustat group.…”